NIS4
LIVE

Serial Number

88384897

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Apr 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NIS4 Trademark

Serial Number: 88384897 • Registration: 6056468

NIS4 is a trademark filed by GENFIT on April 14, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENFIT (44 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

April 14, 2019

Registration Date

May 19, 2020

Published for Opposition

March 3, 2020

Goods & Services

Downloadable software for use in database mining in the field of metabolic disorders and liver diseases and in permitting the transmission and exchange of biological data between users; optical, weighing, measuring and testing scientific apparatus and instruments in the field of clinical research and diagnostics for use in genetic and enzymatic research of metabolic disorders and liver diseases, namely, sequencers, genetic analyzer machines, biochips, and enzymatic activity readers

Pharmaceutical preparations for the prevention and treatment of metabolic disorders and liver diseases; diagnostic preparations for treatment of metabolic disorders and liver diseases; diagnostic testing materials for medical use, namely, reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, chemical product, biomarking agents, blood derived samples namely, plasma, serum, platelets, platelets free samples, red blood cells and white cells all for treatment of metabolic disorders and liver diseases; diagnostic agents for pharmaceutical and medical use, namely, for the treatment of metabolic disorders, liver diseases, medical diagnostic reagents and assays for testing of body fluids for treatment of metabolic disorders and liver diseases, chemical products in the nature of chemical diagnostic preparations for diagnostic tests for medical or clinical use for the diagnostic tests all for treatment of metabolic disorders and liver diseases; radio-isotope markers for therapeutic or diagnostic use for treatment of metabolic disorders and liver diseases

Medical health care consultancy services in the field of metabolic disorders and liver diseases; Medical information in the field of metabolic disorders and liver diseases; compilation of medical reports in the nature of compiling data for research purposes in the field of metabolic disorders and liver diseases; medical science and medical consultancy in the field of metabolic disorders and liver diseases; medical information services provided via the Internet in the field of metabolic disorders and liver diseases; medical diagnostic services in the field of metabolic disorders and liver diseases

Surgical and medical apparatus and instruments, namely, apparatus for measuring NASH, liver fibrosis, cirrhosis, ASH, NAFLD, and liver injury, and non-invasive diagnostic apparatus and instruments for detecting liver injury; tools and instruments for medical diagnostics, namely, diagnostic medical devices for diagnosis of liver diseases, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzers, medical devices for measuring biochemical and physical parameters, namely, concentration of biomarkers relating to the evaluation of liver diseases, and blood analyzers for evaluation of liver diseases

Filing History

TEAS SECTION 8 RECEIVED
May 4, 2026 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 29, 2019 GPRN
PRIORITY ACTION E-MAILED
Jun 29, 2019 GPRA
PRIORITY ACTION WRITTEN
Jun 29, 2019 CPRA
ASSIGNED TO EXAMINER
Jun 22, 2019 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 4, 2019 AMPX
ASSIGNED TO LIE
Jun 4, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
May 30, 2019 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2019 NWOS
NEW APPLICATION ENTERED
Apr 17, 2019 NWAP